Michal Svoboda

Masaryk University — Czech Republic

Medicine · Health Sciences

36h-index5.3kcitations336works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(54), Neuropeptides and Animal Physiology(39), Receptor Mechanisms and Signaling(27), Pancreatic function and diabetes(24), Diabetes Treatment and Management(18)

Publications335 total

The role of autoproteolysis and mitoribosomal proteins in regulation of mitochondrial LACTB tumor suppressor
2025Open Access
Comparison of EV isolation methods from MSCs
Biopolymers and Cell·2025Open Access
High-Intensity Respiratory Muscle Training as Pre-habilitation in Lung Resection Surgery: a randomized controlled trial.
2025
Severe AAT deficiency in the Czech Republic - The reality of care.
2025
Quality of life in patients with lung cancer during the modern anticancer treatment - muticenter prospective data from the Czech Republic
Lung Cancer·2025
First report from the Czech national registry of inborn errors of immunity (2012–2025)
Frontiers in Immunology·2025Open Access
Multimodal prehabilitation before lung resection surgery: a multicentre randomised controlled trial
British Journal of Anaesthesia·2025· 12 citedOpen Access
Effect of Treatment with Mucoactive Drugs on COPD Exacerbations During 5 years of Follow-up in the Czech Republic: A Real-World Study
Lung·2025· 1 citedOpen Access
The lung cancer patient quality of life during the first line of treatment – multicenter prospective data
Klinicka onkologie·2025Open Access
A normal electrocardiogram indicates a better prognosis in patients with moderate to very severe chronic obstructive pulmonary disease
Scientific Reports·2025Open Access
Causes of ventilatory inefficiency in lung resection candidates
ERJ Open Research·2024· 3 citedOpen Access
Specific causes of mortality in patients with chronic obstructive pulmonary disease – a prospective multicenter study.
2024
Effect of 5 years of treatment with mucoactive drugs on COPD exacerbations in the Czech Republic: a real-life study
2024
Post-COVID after hospitalization of COVID-19 patients during the pandemic - monocentric retrospective study
Epidemiology·2024
Pruritus and xerodermia in patients treated with checkpoint inhibitors for melanoma, lung and renal cancer: a meta-analysis
2024Open Access
Aurora: a fluorescent deoxyribozyme for high-throughput screening
Nucleic Acids Research·2024· 7 citedOpen Access
The long-term effect of elexacaftor/tezacaftor/ivacaftor on cardiorespiratory fitness in adolescent patients with cystic fibrosis: a pilot observational study
BMC Pulmonary Medicine·2024· 6 citedOpen Access
New models for prediction of postoperative pulmonary complications in lung resection candidates
ERJ Open Research·2024· 3 citedOpen Access
Nutritional status and muscle mass loss in patients with COPD, association with lung function, symptoms, comorbidities and long-term survival: data from the National Database Study
Biomedical Papers·2024· 3 citedOpen Access
Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor
Digestive Diseases·2024· 22 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Jean Christophe(10), M. Tastenoy(7), Myrna Virreira(6), Patrick Robberecht(6), Faustino Torrico(4), Carine Truyens(4), Cristina Alonso‐Vega(4), Yves Carlier(4), Martina Šterclová(4), Martina Vašáková(4), Wolfgang Weinmann(4), E. Ciccarelli(4), Jan Konvalinka(4), Richard Rokyta(3), Jiří Jarkovský(3), Hing‐Biu Lee(3), Thomas E. Peart(3), Marco Solano(3), Monika Žůrková(3), Vladimíra Lošťáková(3)